PPT-Measure Development Education & Outreach for Specialty Societies & Patient Advocacy

Presenter Kathy Lesh PhD RNBC CPHQ November 1 2017 2 pm Eastern Electronic Clinical Quality Measure eCQM Updates What you need to know Webinar 3 Vision and Goals Webinar Series. Specialty Distributor Specialty PharmacyFaxWebsiteAvella Specialty Pharmacy1-877-546-57791-877-546-5780www.avella.comwww.biologicsinc.com Diplomat Specialty Pharmacy1-877-977-91181-800-550-6272www.dip Christina Hansen, . pharm.d. CHARACTERISTICS. Treat complex and rare disease states. RA, Cancer, Crohn’s, MS. More expensive . Distribution restrictions . Special handling requirements. Continuous monitoring. Julia Deets. VP Sales & Marketing, Metalcraft. What this presentation will cover:. Define “specialty” RFID tagging. When is it required?. Factors to identify in specialty RFID tagging applications. NJASFAA. Agenda. Advocacy 101. Congressional Overview. NASFAA and Advocacy. NASFAA Advocacy Resources. Fight for Financial Aid Campaign. Advocacy and You!. Advocacy 101: What is advocacy?. First Amendment Roots. October 20, 2018. Step 12 invites us to carry Nar-. Anon’s. message of hope to Others. . Spread Awareness!. Objectives for Outreach 2018. Review statistics for new meetings as well as meetings that closed.. Chapter 6. I. Early Societies of . MesoAmerica. Major Pre-Columbian Civilizations. Early Mesoamerican societies . 1200 BCE – 1100 CE. The . Olmecs. 1. Early Agriculture in Mesoamerica . 8000-7000bce. Basics of Care Management and Care Transitions in the Field. Kelly Craig, Director of Care Management Initiatives. Jason . Turi. , Clinical Manager of Care Transitions. July 20, 2012. Camden Coalition of. October 21, 2016. Advocacy & Outreach Committee. Name. Affiliation. Jackie Marchington. Committee Co-chair. Tom Grant. Committee Co-chair. Tanya Brinsden. Novartis. Alice Choi. CMC. John . Czekanski. October 21, 2016. Advocacy & Outreach Committee. Name. Affiliation. Jackie Marchington. Committee Co-chair. Tom Grant. Committee Co-chair. Tanya Brinsden. Novartis. Alice Choi. CMC. John . Czekanski. Presentation by: Delcie Gorum, Esq. . What is a P&A?. In 1975, congress mandated that each state have a Protection and Advocacy (P&A) System to protect the rights and interests of persons with developmental or intellectual disabilities. This system eventually evolved into the modern P&A system which serves individuals with any type of disability. . H 2060 Societies Use the subdivision groups or whose membership is drawn from these groups Such works may discuss methods of or may discuss specific organizations collectively Use the subdivision Building a Business Case. Presenters: . Brenna Rabel, Battelle. Matt Humphrey, RELI. January 23, 2019. 2:00-3:00pm EST. . Vision and Goals: . MACRA Info Sessions. CMS Measure Development Education & Outreach. An integrated health system model. _______, PharmD. Objectives . Define Specialty Pharmacy. Review Specialty Pharmacy operations & services. Provide Specialty Pharmacy contact information . Explain the medication access process . of Cleft Lip and Cleft Lip and Palate. Matthew Yoder. 1. , Scott Hickey, MD. 2. Division of Genetics. The Research Institute at. Nationwide Children’s Hospital. Columbus, Ohio. College of Medicine.